Targretin Topical Gel 1pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Targretin: Topical gel (1%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

BEXAROTENE (bexs AIR oh teen) is used to treat skin lesions in patients with cutaneous T-cell lymphoma.

In-Depth Information
Select a Medication

Targretin 1% Topical Gel

NDC: 643650504
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Mycosis Fungoides, Cutaneous T-cell Lymphoma (CTCL)

Storage Information
Protect from light
Avoid excessive humidity
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Avoid excessive heat (above 104 degrees F)
Targretin 1% Topical Gel

Reported Side Effects for Targretin 1% Topical Gel

Skin Irritation Incidence:
<72.0%*
Severity: MILD
Onset: EARLY
Rash With Pustules Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Skin Redness Incidence:
<72.0%*
Severity: MODERATE
Onset: EARLY
Infection Incidence:
<7.6%*
Severity: SEVERE
Onset: DELAYED
Excessive Sweating Incidence:
<6.0%*
Severity: MILD
Onset: DELAYED
Exfoliative Dermatitis Incidence:
<28.3%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
1.2-20.8%*
Severity: SEVERE
Onset: DELAYED
Skin Rash Incidence:
1.9-3.6%*
Severity: SEVERE
Onset: EARLY
Headache Incidence:
3.6-11.3%*
Severity: SEVERE
Onset: EARLY
Low White Blood Cell Counts Incidence:
3.6-13.2%*
Severity: SEVERE
Onset: DELAYED
Sore Throat Incidence:
6.0-10.0%*
Severity: MILD
Onset: DELAYED
Enlarged Lymph Nodes Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Paresthesias Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Cough Incidence:
6.0-10.0%*
Severity: MILD
Onset: DELAYED
Allergic Skin Reaction Incidence:
8.0-14.0%*
Severity: MODERATE
Onset: DELAYED
Swelling Incidence:
10.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cells Incidence:
15.6-26.4%*
Severity: SEVERE
Onset: DELAYED
Itching Incidence:
18.0-40.0%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Targretin

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5